Sat Kartar Life
SATKARTAR NSE
Sat Kartar Life
HealthcareNSE: SATKARTAR Pharmaceuticals & Biotechnology
Key Fundamentals
SMEPharmaceuticalsHealthcareMarket Cap
₹226 Cr
Volatility
Moderate
P/E Ratio
12.1
EBITDA
₹27.10 Cr
Return on Equity
25.3%
Debt to Equity
0.03
Book Value
₹43.34
52W High
₹219.8
52W Low
₹110.3
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
3- Company has reduced debt.
- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 33.0%
Weaknesses
1- Working capital days have increased from 28.3 days to 60.9 days
Growth Rate
Revenue Growth
24.07% lower than
3Y
Net Income Growth
74.49% lower than
3Y
Cash Flow Change
109% higher than
3Y
ROE
32.74%
ROCE
34.02%
EBITDA Margin (Avg.)
45.74%
Quarterly Results
| Particulars | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Sales | 75 | 76 | 87 | 88 | 105 |
| Expenses | 69 | 70 | 79 | 78 | 91 |
| Operating Profit | 6 | 6 | 9 | 10 | 14 |
| OPM % | 8% | 7% | 10% | 12% | 14% |
| Other Income | 0 | 0 | 1 | 2 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 2 |
| PBT | 5 | 5 | 8 | 11 | 13 |
| Tax % | 27% | 25% | 25% | 26% | 26% |
| Net Profit | 4 | 4 | 6 | 8 | 9 |
| EPS in Rs | 13.29 | 3.3 | 3.8 | 4.95 | 6.01 |
Profit & Loss
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Sales | 52 | 83 | 128 | 163 | 194 |
| Expenses | 49 | 78 | 118 | 149 | 169 |
| Operating Profit | 3 | 5 | 10 | 14 | 25 |
| OPM % | 5% | 6% | 8% | 9% | 13% |
| Other Income | 0 | 0 | 0 | 1 | 2 |
| Interest | 0 | 0 | 1 | 1 | 1 |
| Depreciation | 1 | 1 | 1 | 1 | 3 |
| PBT | 2 | 3 | 9 | 13 | 23 |
| Tax % | 7% | 27% | 27% | 25% | 26% |
| Net Profit | 1 | 3 | 6 | 10 | 17 |
| EPS in Rs | 1.99 | 3.59 | 22.54 | 6.24 | 10.96 |
| Div. Payout % | 0% | 0% | 3% | 11% | 6% |
Balance Sheet
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Equity Capital | 0.7 | 0.7 | 3 | 16 | 16 |
| Reserves | 0 | 3 | 7 | 36 | 52 |
| Borrowings | 8 | 4 | 2 | 6 | 2 |
| Other Liabilities | 3 | 8 | 11 | 7 | 14 |
| Total Liabilities | 12 | 15 | 22 | 65 | 84 |
| Fixed Assets | 5 | 4 | 8 | 6 | 11 |
| CWIP | 0 | 0 | 0 | 0 | 1 |
| Investments | 0 | 0 | 0 | 0 | 1 |
| Other Assets | 8 | 11 | 14 | 58 | 71 |
| Total Assets | 12 | 15 | 22 | 65 | 84 |
Cash Flow
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating | — | — | 7 | -5 | 0 |
| Investing | — | — | -3 | 0 | -9 |
| Financing | — | — | -3 | 34 | -1 |
| Net Cash Flow | — | — | 2 | 28 | -9 |
| Free Cash Flow | — | — | 7 | -10 | -7 |
| CFO/OP | — | — | 98 | -13 | 26 |
Ratios
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debtor Days | 1 | 0 | 7 | 13 | 26 |
| Inventory Days | 31 | 25 | 23 | 185 | 258 |
| Days Payable | 165 | 226 | 237 | 170 | 293 |
| Cash Conversion Cycle | -134 | -200 | -208 | 29 | -9 |
| Working Capital Days | 1 | -14 | -7 | 31 | 61 |
| ROCE % | — | 50% | 98% | 40% | 36% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Sat Kartar Life insights
58 extracted metrics + investor summaries across FY22–FY26.
Documents
1
Analysts/Institutional Investor Meet/Con. Call Updates
3 Sep - Analyst visit and management meet at Sat Kartar Sanjeevan Hospital on 9 September 2026. 3 Sep - Analyst visit and management meet at Sat Kartar Sanjeevan Hospital on 9 September 2026.
2
Shareholders meeting
31 Aug - Sat Kartar Life’s 28 Aug 2026 AGM resolutions passed, including dividend, director and auditor reappointments. 31 Aug - Sat Kartar Life’s 28 Aug 2026 AGM resolutions passed, including dividend, director and auditor reappointments.
3
Appointment
31 Aug - Shareholders approved reappointment of M/s. Nidhi Bansal & Co. as statutory auditor for five years. 31 Aug - Shareholders approved reappointment of M/s. Nidhi Bansal & Co. as statutory auditor for five years.
4
Shareholders meeting
28 Aug - 14th AGM held on 28 Aug 2026; shareholders approved ₹0.70 final dividend and key routine resolutions. 28 Aug - 14th AGM held on 28 Aug 2026; shareholders approved ₹0.70 final dividend and key routine resolutions.
5
Analysts/Institutional Investor Meet/Con. Call Updates
6 Aug - Sat Kartar Life to hold one-on-one virtual investor meeting with Prijal Investment on 11 August 2026. 6 Aug - Sat Kartar Life to hold one-on-one virtual investor meeting with Prijal Investment on 11 August 2026.
Frequently Asked Questions about Sat Kartar Life
What does Sat Kartar Life Ltd do?
Incorporated in June 2012, Sat Kartar Shopping Limited is an Ayurveda healthcare company that delivers natural wellness solutions for therapeutic and lifestyle products.[1]
Where is Sat Kartar Life Ltd (SATKARTAR) listed?
Sat Kartar Life Ltd trades as SATKARTAR on the NSE.
Which sector does Sat Kartar Life Ltd belong to?
Sat Kartar Life Ltd is classified under the Healthcare sector, in the Pharmaceuticals & Biotechnology industry.
What is the market capitalisation of Sat Kartar Life Ltd?
Sat Kartar Life Ltd has a market capitalisation of ₹225.87 Cr, which places it in the Small Cap band.
What is the PE ratio of Sat Kartar Life Ltd?
Sat Kartar Life Ltd trades at a PE ratio of 12.10, against a book value of ₹43.34 per share.
What is the 52-week high and low of Sat Kartar Life Ltd?
Over the last 52 weeks Sat Kartar Life Ltd has traded between ₹110.3 and ₹219.8.
Does Sat Kartar Life Ltd pay dividends?
Sat Kartar Life Ltd has a dividend yield of 0.53%.
What is the Return on Equity (ROE) of Sat Kartar Life Ltd?
Sat Kartar Life Ltd reported a return on equity of 25.30%. Its debt-to-equity ratio is 0.03.
Company Information
Incorporated in June 2012, Sat Kartar Shopping Limited is an Ayurveda healthcare company that delivers natural wellness solutions for therapeutic and lifestyle products.[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/SATKARTAR.md for Sat Kartar Life Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.